Delphine Girlich
Overview
Explore the profile of Delphine Girlich including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
95
Citations
1222
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Girlich D, Jousset A, Emeraud C, Rezzoug I, Burwell R, Singh P, et al.
Pathogens
. 2024 Sep;
13(9).
PMID: 39338914
As bloodstream infections and associated septic shock are common causes of mortality in hospitals, rapid antibiotic susceptibility testing (AST) performed directly on positive blood cultures is needed to implement an...
2.
Emeraud C, Bernabeu S, Girlich D, Rezzoug I, Jousset A, Birer A, et al.
Emerg Infect Dis
. 2024 Sep;
30(10):2178-2182.
PMID: 39320334
We examined the emergence and characteristics of oxacillinase-484-producing Enterobacterales in France during 2012-2023. Genomic analysis identified 2 predominant sequence types in Escherichia coli: ST410 and ST1722. Plasmid analysis revealed that...
3.
Vanparis O, Oueslati S, Girlich D, Jousset A, Guyot C, Delaval A, et al.
J Antimicrob Chemother
. 2024 Sep;
79(12):3186-3190.
PMID: 39319679
Objectives: This study described OXA-1186, a novel carbapenemase related to OXA-198 carbapenemase and produced by a clinical isolate of Citrobacter freundii. Methods: WGS was used to characterize the resistome, virulome...
4.
Daaboul D, Osman M, Kassem I, Yassine I, Girlich D, Proust A, et al.
J Antimicrob Chemother
. 2024 May;
79(7):1614-1618.
PMID: 38804143
Background: Carbapenem-resistant Pseudomonas aeruginosa are being increasingly described worldwide. Here, we investigated the molecular mechanisms underlying carbapenem resistance in an extremely drug-resistant P. aeruginosa isolate from a neonatal intensive care...
5.
Emeraud C, Girlich D, Deschamps M, Rezzoug I, Jacquemin A, Jousset A, et al.
Emerg Infect Dis
. 2024 May;
30(6):1279-1282.
PMID: 38782383
We characterized a collection of IMI-like-producing Enterobacter spp. isolates (n = 112) in France. The main clone corresponded to IMI-1-producing sequence type 820 E. cloacae subspecies cloacae that was involved...
6.
Bonnin R, Creton E, Perrin A, Girlich D, Emeraud C, Jousset A, et al.
Lancet Microbe
. 2024 Apr;
5(6):e547-e558.
PMID: 38677305
Background: Morganella spp are opportunistic pathogens involved in various infections. Intrinsic resistance to multiple antibiotics (including colistin) combined with the emergence of carbapenemase producers reduces the number of active antimicrobials....
7.
Marin-Esteban V, Molet L, Lagana M, Ciocan D, Dominguez-Lafage C, Alouche N, et al.
N Engl J Med
. 2024 Apr;
390(14):1339-1341.
PMID: 38598804
No abstract available.
8.
Yousfi C, Oueslati S, Daaboul D, Girlich D, Proust A, Bentchouala C, et al.
Microorganisms
. 2024 Mar;
12(3).
PMID: 38543576
Abscesses represent the most prominent emerging problem in the red meat industry, leading to great economic constraints and public health hazards. Data on etiological agents present in these purulent lesions...
9.
Daaboul D, Kassem I, Yassine I, Hamze M, Dabboussi F, Girlich D, et al.
J Antimicrob Chemother
. 2024 Feb;
79(4):923-925.
PMID: 38297956
No abstract available.
10.
Rezzoug I, Emeraud C, Girlich D, Creton E, Naas T, Bonnin R, et al.
J Antimicrob Chemother
. 2024 Jan;
79(3):683-685.
PMID: 38197500
No abstract available.